Labels Or Markers Utilized (e.g., Radiotracer, Affinity, Fluoroescent, Phosphorescent, Markers, Etc.) Patents (Class 536/25.32)
-
Patent number: 7919322Abstract: The present invention provides methods, nucleic acid constructs, and kits for selectively deleting a region of a nucleic acid sequence. Specifically, it utilizes retargeting retroelements to place site-specific recombination sites at targeted locations in the nucleic acid sequence. The region between the recombination sites is then deleted using a site-specific recombination system.Type: GrantFiled: March 29, 2006Date of Patent: April 5, 2011Assignee: Sigma-Aldrich Co.Inventors: Melissa Spears, Greg Davis, Kevin Kayser
-
Patent number: 7919247Abstract: A process for assessing mitochondrial toxicity of a compound that includes contacting nucleic acids from a host with an amplification reaction mixture that contains at least two primers that provide detectable signals, wherein: a first primer provides a first detectable signal upon amplification of a host mitochondrial nucleic acid; a second primer provides a second detectable signal upon amplification of a host nuclear nucleic acid; and comparing the first and second detectable signals.Type: GrantFiled: December 3, 2007Date of Patent: April 5, 2011Assignee: Pharmasset, Inc.Inventors: Lieven Stuyver, Michael J. Otto
-
Publication number: 20110077389Abstract: Novel CE-phosphoramidites and CPG reagents have been synthesized from a serinol backbone. These reagents are useful to introduce functional groups or directly label oligonucleotides. The versatile serinol scaffold allows for labeling at any position (5? or 3? termini, or any internal position) during automated DNA synthesis. Multiple labels or functional groups can be achieved by repetitive coupling cycles. Optimal spacer arms and protected label moieties have been specially designed. Further, the natural 3-carbon atom internucleotide phosphate distance is retained when inserted internally.Type: ApplicationFiled: September 28, 2010Publication date: March 31, 2011Applicants: Nelson Biotechnologies, Inc., Glen Research CorporationInventors: Paul S. Nelson, Hugh Mackie, Andrew Murphy
-
Publication number: 20110065907Abstract: The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. In particular, the methods include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.Type: ApplicationFiled: October 28, 2010Publication date: March 17, 2011Applicant: President and Fellows of Harvard CollegeInventors: Adrian Salic, Timothy J. Mitchison
-
Patent number: 7906280Abstract: The present invention describes methods for the production and use of single chain (single-stranded) fluorescence resonance energy transfer (“FRET”) DNA or RNA aptamers containing fluorophores (F) and quenchers (Q) at various loci within their structures, such that when its specific matching analyte is bound and the FRET-aptamers are excited by specific wavelengths of light, the fluorescence intensity of the system is modulated (increased or decreased) in proportion to the amount of analyte added. F and Q are covalently linked to nucleotide triphosphates (NTPs), which are incorporated by various nucleic acid polymerases such as Taq polymerase during the polymerase chain reaction (PCR) and then selected by affinity chromatographic, size-exclusion or molecular sieving, and fluorescence techniques. Further separation of related FRET-aptamers can be achieved by ion-pair reverse phase high performance liquid chromatography (HPLC) or other types of chromatography.Type: GrantFiled: May 12, 2006Date of Patent: March 15, 2011Inventors: John G. Bruno, Joseph Chanpong
-
Publication number: 20110059458Abstract: The present invention relates compositions and methods that are useful in catalyzing DNA-Programmed Chemistry (or Nucleic Acid-templated chemistry) for use in therapeutic and diagnostic applications.Type: ApplicationFiled: February 20, 2009Publication date: March 10, 2011Inventors: Yumei Huang, James M. Coull, David J. Livingston
-
Patent number: 7897737Abstract: Provided are novel nucleotides, nucleoside, and their derivatives described herein, that can be used in DNA sequencing technology and other types of DNA analysis. In one embodiment, the nucleotide or nucleoside with an unprotected 3?-OH group is derivatized at the nucleobase to include a fluorescent dye attached via a linker to a photocleavable terminating group. The photocleavable-fluorescent group is designed to terminate DNA synthesis as well as be cleaved so that DNA oligomers can be sequenced efficiently in a parallel format. The design of such rapidly cleavable fluorescent groups on nucleotides and nucleosides can enhance the speed and accuracy of sequencing of large oligomers of DNA in parallel, to allow rapid whole genome sequencing, and the identification of polymorphisms and other valuable genetic information, as well as allowing further manipulation and analysis of nucleic acid molecules in their native state following cleavage of the fluorescent group.Type: GrantFiled: December 5, 2006Date of Patent: March 1, 2011Assignee: LaserGen, Inc.Inventors: Weidong Wu, Vladislav A. Litosh, Brian P. Stupi, Michael L. Metzker
-
Patent number: 7893227Abstract: Provided are novel nucleotides, nucleoside, and their derivatives described herein, that can be used in DNA sequencing technology and other types of DNA analysis. In one embodiment, the nucleotide or nucleoside with an unprotected 3?-OH group is derivatized at the nucleobase to include a fluorescent dye attached via a linker to a non-cleavable terminating group. The non-cleavable-fluorescent group is designed to terminate DNA synthesis so that DNA oligomers can be sequenced efficiently in a parallel format. These reagents and methods will lead to more accurate identification of polymorphisms and other valuable genetic information.Type: GrantFiled: December 5, 2006Date of Patent: February 22, 2011Assignee: LaserGen, Inc.Inventors: Weidong Wu, Vladislav A. Litosh, Brian P. Stupi, Michael L. Metzker
-
Publication number: 20110020804Abstract: This application provides photoinduced electron transfer (PET) nucleic acid molecules that can be used detect and amplify nucleic acid molecules, such as target nucleic acid molecules. These PET tags can be attached to the 5?-end of a target sequence-specific primer, thereby generating a PET primer. In particular examples, a PET tag includes a 5?-labeled nucleotide that can be quenched by at least two consecutive Gs within the tag sequence, and is unquenched when the PET tag hybridizes with its complementary nucleic acid molecule. Also disclosed are methods of using PET primers in nucleic acid amplification, such as real-time PCR.Type: ApplicationFiled: November 21, 2008Publication date: January 27, 2011Inventors: Jothikumar Narayanan, Vincent Hill, Brian Holloway
-
Patent number: 7875713Abstract: Derivatized cucurbiturils and cucurbituril assemblies formed thereby are disclosed. Also disclosed are binding pairs of the disclosed cucurbituril assemblies and polyamine structures, which are highly advantageous over the presently known affinity pairs and therefore can be efficiently utilized in a myriad of applications.Type: GrantFiled: September 5, 2004Date of Patent: January 25, 2011Assignee: Technion Research & Development Foundation Ltd.Inventor: Ehud Keinan
-
Publication number: 20110015096Abstract: Multiplex barcoded Paired-End Ditag (mbPED) library construction for ultra high throughput sequencing is disclosed. The mbPED library comprises multiple types of barcoded Paired-End Ditag (bPED) nucleic acid fragment constructs, each of which comprises a unique barcoded adaptor, a first tag, and a second tag linked to the first tag via the barcoded adaptor. The two tags are the 5?- and 3?-ends of a nucleic acid molecule from which they originate. The barcoded adaptor comprises a barcode, a first polynucleotide sequence comprising a first restriction enzyme (RE) recognition site, and a second polynucleotide sequence comprising a second RE recognition site and covalently linked to the first polynucleotide sequence via the barcode. The two REs lead to cleavage of a nucleic acid at a defined distance from their recognition sites. The length of the adaptor is set so that the bPED nucleic acid fragment fits one-step sequencing.Type: ApplicationFiled: November 2, 2009Publication date: January 20, 2011Applicant: ACADEMIA SINICAInventor: KUO PING CHIU
-
Patent number: 7871767Abstract: The present invention relates to a polymorphic CYP2C8-polynucleotide. Moreover, the invention relates to genes or vectors comprising the polynucleotides of the invention and to a host cell genetically engineered with the polynucleotide or gene of the invention. Further, the invention relates to methods for producing molecular variant polypeptides or fragments thereof, methods for producing cells capable of expressing a molecular variant polypeptide and to a polypeptide or fragment thereof encoded by the polynucleotide or the gene of the invention or which is obtainable by the method or from the cells produced by the method of the invention. Furthermore, the invention relates to an antibody which binds specifically the polypeptide of the invention. Moreover, the invention relates to a transgenic non-human animal. The invention also relates to a solid support comprising one or a plurality of the above mentioned polynucleotides, genes, vectors, polypeptides, antibodies or host cells.Type: GrantFiled: May 31, 2002Date of Patent: January 18, 2011Assignee: PGxHealth, LLCInventors: Anja Penger, Reimund Sprenger, Ulrich Brinkmann
-
Patent number: 7872120Abstract: Methods for synthesizing a collection of partially identical polynucleotides are disclosed.Type: GrantFiled: August 10, 2007Date of Patent: January 18, 2011Inventor: Venkata Chalapathi Rao Koka
-
Patent number: 7858772Abstract: The present invention provides methods of extending nucleic acids and purifying target nucleic acids. The methods include the use of capping reagents to effect chain termination and provide a handle for purification via fluorous affinity methods.Type: GrantFiled: December 18, 2007Date of Patent: December 28, 2010Assignee: Roche Molecular Systems, Inc.Inventors: Amar Gupta, Stephen Will
-
Patent number: 7858320Abstract: A method for labeling biological molecules and synthetic molecules that contain a geminal diol, such as RNA, carbohydrates or glycoproteins, using a periodate sequestering agent is provided. Compositions and kits for use in the labeling method are also provided.Type: GrantFiled: October 31, 2008Date of Patent: December 28, 2010Assignee: BioVentures, Inc.Inventors: Elliott P. Dawson, Kristie E. Womble
-
Patent number: 7855285Abstract: A process for providing regiospecific and highly stereoselective synthesis of 9-? anomeric purine nucleoside analogs is described. The introduction of the sugar moiety on to 6-(azolyl)-substituted purine bases is performed so that highly stereoselective formation of the ? anomers of only the 9 position regioisomers of the purine nucleoside analogs (either D or L enantiomers) is obtained. This regiospecific and stereoselective introduction of the sugar moiety allows the synthesis of nucleoside analogs, and in particular 2?-deoxy, 3?-deoxy, 2?-deoxy-2?-halo-arabino and 2?,3?-dideoxy-2?-halo-threo purine nucleoside analogs, in high yields without formation of the 7-positional regioisomers. Processes for providing novel 6-(azolyl)purines for the regiospecific and highly stereoselective synthesis of 9-? anomeric purine nucleoside analogs are described. The compounds are drugs or intermediates to drugs.Type: GrantFiled: June 14, 2006Date of Patent: December 21, 2010Assignee: Brigham Young UniversityInventors: Morris J. Robins, Minghong Zhong
-
Patent number: 7842505Abstract: A fluorescent labeling reagent of the present invention includes an inorganic fluorescent particle and a material (A) having a material (B) of biological origin adsorbed or bound thereto. The inorganic fluorescent particle is integrated with the material (A) so as to form the reagent of the present invention. The inorganic fluorescent particle used in the present invention is capable of emitting light with a wavelength of 650 nm to 1600 nm in the infrared region or the near-infrared region which can be detected by means of Si—CCD or InGaAs—PD and can penetrate an H2O rich sample when excited by light with a wavelength of 650 nm or longer which has the shortest transparent wavelength of AlInGaP-LD including oxygen adsorption type hemoglobin used for DVDs etc.Type: GrantFiled: February 26, 2007Date of Patent: November 30, 2010Assignee: Keio UniversityInventors: Kunihiro Noda, Ryo Asakura, Daisuke Saito, Tetsuhiko Isobe, Tomohiro Takagi, Hideki Aizawa, Michio Ohkubo
-
Patent number: 7824863Abstract: In one aspect of the invention, a method is provided for end-labeling RNA (total RNA, mRNA, cRNA or fragmented RNA). In one aspect of the present invention, T4 RNA ligase is used to attach a 3?-labeled AMP or CMP donor to an RNA acceptor molecule. In another embodiment, a pyrophosphate molecule 3?-AppN-3?-linker-detectable moiety is used as donor molecule.Type: GrantFiled: October 22, 2008Date of Patent: November 2, 2010Assignee: Affymetrix, Inc.Inventors: Kyle B. Cole, Vivi Truong, Glenn H. McGall, Anthony D. Barone
-
Patent number: 7811754Abstract: Methods and apparatus for detecting single nucleotide polymorphisms in genes of interest are disclosed. A plurality of probes is immobilized on a planar waveguide. The probes comprise sequences complementary to a wildtype sequence of the gene of interest and complementary to a sequence of a known SNP in the gene of interest. A fluorescently-labeled analyte is flowed over the planar waveguide. The binding between the labeled analyte and each of the probes causes a change in the fluorescence signal. The SNP is detected by comparing the hybridization kinetics of the analyte with each of the probes. A method of detecting single nucleotide polymorphisms in a gene of interest by sequencing by hybridization is also disclosed.Type: GrantFiled: September 9, 2004Date of Patent: October 12, 2010Assignee: University of Utah Research FoundationInventors: James N. Herron, Samuel Tolley, Hsu-Kun Wang
-
Patent number: 7807350Abstract: The present invention concerns the methods and compositions for evaluating the risk of ironotecan toxicity in a cancer patient based on the genotype of the patient at position ?3156 of the UGT1A1 gene or at any position in linkage disequilibrium with the ?3156 variant.Type: GrantFiled: May 28, 2004Date of Patent: October 5, 2010Assignee: The University of ChicagoInventors: Mark J. Ratain, Federico Innocenti, Anna Di Rienzo, Carrie Grimsley
-
Publication number: 20100248385Abstract: An oligonucleotide-based molecular probe includes at least one pin loop, the pin loop including a loop sequence complementary to a target sequence. A first stem sequence is attached to one end of the pin loop, the first stem having at least one fluorescent label attached thereto. A second stem sequence is attached to the other end of the pin loop. The second stem has a plurality of quencher molecules attached thereto.Type: ApplicationFiled: June 17, 2005Publication date: September 30, 2010Applicant: University of Florida Research Foundation, Inc.Inventors: Weihong Tan, Chaoyong Yang
-
Patent number: 7803528Abstract: A method is provided for detecting the presence of nucleotides or monitoring nucleotide amplification. It utilizes fluorescence energy transfer by competitive hybridization. Competitive hybridization is achieved by using unequal length complementary probes which have a fluorophore on one probe and a quencher on the other. The fluorophore and quencher are juxtaposed in a manner wherein the proximity of the quencher to the fluorophore produces quenching of the fluorescence of the fluorphore.Type: GrantFiled: February 26, 1998Date of Patent: September 28, 2010Assignee: Quest Diagnostics IncorporatedInventors: Chih-Sheng Chiang, Jose F Cuan
-
Patent number: 7803540Abstract: A method of increasing discrimination for a target DNA having a polymorphic site is provided. The method comprising immobilizing first and second probes on a substrate; hybridizing the immobilized first and second probes with first and second hurdle DNAs, respectively; and hybridizing the target DNA with the hybrids, and determining the ratio of a signal of the target DNA hybridized to the first probe to a signal of the target DNA hybridized to the second probe. The addition of a hurdle DNA and variation of a probe base can improve an ability of discriminating a single base mismatch.Type: GrantFiled: January 19, 2006Date of Patent: September 28, 2010Assignee: Samsung Electronics Co., Ltd.Inventors: Soo-hyung Choi, Jang-seok Ma, Joon-shik Park, Ji-young Oh, Jong-suk Chung
-
Publication number: 20100240103Abstract: An embodiment of the invention discloses new methods for designing labeled nucleic acid probes and primers by labeling oligonucleotides with a plurality of spectrally identical or similar dyes and optionally with one or more quencher dyes. Oligonucleotides labeled in accordance with some embodiments of the invention exhibit a detectable increase in signal, for example, fluorescent signal when the labeling dyes are separated from one another. Methods for separating the dye include cleaving the labeled oligonucleotides include using enzymes that have 5?-exonuclease activity. In one embodiment nucleic acid primers of the present invention may fluoresce upon hybridization to a target sequence and incorporation into the amplification product. Nucleic acid probes and primers of the present invention have wide applications ranging from general detection of a target nucleic acid sequence to clinical diagnostics.Type: ApplicationFiled: December 23, 2009Publication date: September 23, 2010Inventors: Fei Mao, Xing Xin
-
Patent number: 7795423Abstract: The present invention provides a new labeling reagent for preparing modified oligonucleotides and processes for their production wherein these oligonucleotides contain at least once the structure P?N—SO2-benzole-L-M-X, characterized in that L is either —(CH2)n- or polyethylene glycol, M is selected from a group consisting of —NH—, —O—, —S—, and —COO—, and X is either a protecting group or a detectable unit. L is preferably either —(CH2)n- or polyethylene glycol.Type: GrantFiled: May 20, 2008Date of Patent: September 14, 2010Assignee: Roche Diagnostics Operations, Inc.Inventor: Dieter Heindl
-
Publication number: 20100222563Abstract: A method for modifying nucleic acid bases by a chemical means, which enables the discrimination of every base species in plural species of bases in a nucleic acid comprising plural nucleotide units, while retaining the base sequence information of the nucleic acid. A nucleic acid base-modified product provided by the method. The nucleic acid base-modified product is essentially a single strand. In accordance with the invention, a novel means for sequencing a nucleic acid by a microscopic means is provided.Type: ApplicationFiled: August 8, 2008Publication date: September 2, 2010Inventors: Masanori Kataoka, Kuniaki Nagayama
-
Patent number: 7786294Abstract: A method of producing a polydeoxyribonucleotide molecule by reverse transcriptase polymerase chain reaction wherein the polydeoxyribonucleotide molecule has a length of greater than 5,000 base-pairs is disclosed. The method involves combining two reverse transcriptases followed by two protocols of polymerase chain reaction. This method enable the amplification of large DNAs, such as viruses, from a sample while preserving genetic diversity of the large DNA.Type: GrantFiled: May 31, 2007Date of Patent: August 31, 2010Assignee: Saint Louis UniversityInventors: Xiaofeng Fan, Adrian M. Di Bisceglie
-
Patent number: 7786279Abstract: Polynucleotides and polypeptides which participate in influenza virus infection of cells and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and antibodies directed thereagainst for diagnosing, treating and preventing influenza virus infection.Type: GrantFiled: February 24, 2004Date of Patent: August 31, 2010Assignee: Yeda Research And Development Co. Ltd.Inventors: Ruth Arnon, Sung-Ho Jeon, Basak Kayhan, Tamar Ben-Yedidia
-
Publication number: 20100213059Abstract: The invention relates transiently attaching drag-tags to molecules during electrophoresis. The invention includes running buffers having drag-tags that transiently attach to lipophilic moieties attached to the molecules. The lipophilic moieties can be covalently or ionically bonded to the molecules. One particular aspect of the invention is a nucleoside analog or a nucleic acid analog comprising a lipophilic moiety. The invention is also directed to methods of separating molecules that comprise a lipophilic moiety. The methods generally comprise transiently attaching a drag-tag to the lipophilic moiety during a separation modality. These methods can be used to separate the molecules by size or weight, to measure a hydrodynamic radius of a drag-tag, or to separate a plurality of drag-tag by their hydrodynamic radius.Type: ApplicationFiled: June 23, 2008Publication date: August 26, 2010Applicant: CARNEGIE MELLON UNIVERSITYInventors: James W. Schneider, Shane T. Grosser, Jeffrey M. Savard
-
Publication number: 20100216984Abstract: The present invention provides compounds of the formula (I): C-Q-O—Si(R1)(R2)—N wherein C is a chromophore; Q is selected from the group consisting of optionally substituted aliphatic, aryl, heteroaryl, cycloalkyl or heterocycloalkyl; R1 and R2 are independently selected from the group consisting of optionally substituted C1-8 alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-8 alkyloxy, cycloalkyloxy, heterocycloalkyloxy, alkylsilyloxy and arylsilyloxy; and N is a glycosylamine or abasic moiety.Type: ApplicationFiled: May 16, 2008Publication date: August 26, 2010Applicant: Dharmacon, Inc.Inventor: Michael Oren Delaney
-
Patent number: 7771929Abstract: Families of compositions are provided as labels, referred to as eTag reporters for attaching to polymeric compounds and assaying based on release of the eTag reporters from the polymeric compound and separation and detection. For oligonucleotides, the eTag reporters are synthesized at the end of the oligonucleotide by using phosphite or phosphate chemistry, whereby mass-modifying regions, charge-modifying regions and detectable regions are added sequentially to produce the eTag labeled reporters. By using small building blocks and varying their combination large numbers of different eTag reporters can be readily produced attached to a binding compound specific for the target compound of interest for identification. Protocols are used that release the eTag reporter when the target compound is present in the sample.Type: GrantFiled: April 18, 2003Date of Patent: August 10, 2010Assignee: Monogram Biosciences, Inc.Inventors: Sharat Singh, Tracy Matray, Hossein Salimi-Moosavi
-
Patent number: 7767400Abstract: The disclosure provides methods of generating paired reads in sequencing-by-synthesis process, particularly, in systems with relatively short read lengths (e.g., 15-35bases), such as for example, in single molecule sequencing by synthesis. Several implementations of the methods are provided. Of particular advantage are the methods that permit re-sequencing of the template, which yields lower error rates. The invention further provides methods of using paired reads, for example, for positioning them over repeats or for assembly into large sequences, including whole genome assembly.Type: GrantFiled: February 3, 2008Date of Patent: August 3, 2010Assignee: Helicos Biosciences CorporationInventor: Timothy D. Harris
-
Publication number: 20100178242Abstract: The invention provides a method for radiofluorination of biological vectors such as peptides comprising reaction of a compound of formula (II): or a salt thereof with a source of [18F]-fluoride, to give a compound of formula (I): or a salt thereof.Type: ApplicationFiled: June 18, 2008Publication date: July 15, 2010Inventors: Alexander Jackson, Rajiv Bhalla
-
Patent number: 7745180Abstract: Disclosed are a method, device kit, and automated system for simple, reproducible, and high-throughput quantification of mRNA from whole blood. More particularly, the method, device, kit and automated system involve combinations of leukocyte filters attached to oligo(dT)-immobilized multi-well plates.Type: GrantFiled: March 9, 2004Date of Patent: June 29, 2010Assignees: Hitachi Chemical Co., Ltd., Hitachi Chemical Research Center, Inc.Inventor: Masato Mitsuhashi
-
Patent number: 7741471Abstract: The present invention provides the combination of the O-2 diphenylcarbamoyl (“DPC”) and N-6 dimethylaminomethylidene (“DMF”) protecting groups for isoguanosine nucleosides that can be utilized in oligonucleotide synthesis.Type: GrantFiled: May 26, 2005Date of Patent: June 22, 2010Assignee: EraGen Biosciences, Inc.Inventors: James R. Prudent, Christopher B. Sherrill
-
Patent number: 7737089Abstract: The present invention relates to a process for synthesizing biopolymers by stepwise assembly from protected synthesis building blocks which carry two-stage protective groups. The two-stage protective groups are activated by a first illumination step and eliminated by a subsequent chemical treatment step. Photoactivatable components which considerably speed up the activation process via intramolecular triplet sensitizers or/and have fluorescence properties are used. The two-stage protective groups can be used in particular within the framework of quality control.Type: GrantFiled: December 23, 2003Date of Patent: June 15, 2010Assignee: Febit Holding GmbHInventors: Ramon Güimil, Matthias Scheffler, Barbro Beijer
-
Patent number: 7723495Abstract: To provide an amidite for nucleic acid synthesis, which enables a protective group therein to be removed under moderate conditions and can be practically used, and a nucleic acid synthesizing method using the amidite for nucleic acid synthesis. Specifically, the present invention relates to an amidite for nucleic acid synthesis represented by General Formula (I) below, and a nucleic acid synthesizing method using the amidite for nucleic acid synthesis: where X denotes a base; Y denotes a protective group formed of any one of a 4-aminobutyric acid derivative, an o-aminomethylbenzoic acid derivative, an o-aminophenylacetic acid derivative, an o-aminoethylbenzoic acid derivative, an o-aminomethylphenylacetic acid derivative, an o-aminophenylpropionic acid derivative and a 5-aminovaleric acid derivative; and Q denotes one of a hydrogen atom and a hydroxyl group.Type: GrantFiled: November 28, 2007Date of Patent: May 25, 2010Assignee: Fujitsu LimitedInventors: Tsuyoshi Fujihara, Shozo Fujita
-
Publication number: 20100105089Abstract: A biotag that includes a biomolecule that includes a bio polymer sequence; an attaching polymer attached at an endpoint of the biopolymer sequence; and a quantum dot bound to the attaching polymer causing the attaching polymer to become fluorescently labeled is provided. Suggested biomolecules include, but are not limited to, peptides, proteins, amino acids, nucleic acids, deoxyribonucleic acids, ribonucleic acids, and peptide nucleic acids. The biopolymer sequence may be or otherwise include a protein sequence. The biomolecule may be located inside a cell, outside a cell, or on a cell. Desirably, a quantum dot is bound to an attaching polymer and, thus the biomolecule, without using any of thiol chemistries, 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide/N-hydroxysuccinimide hydrochloride (EDC/NHS) chemistries, and biotin/avidin chemistries.Type: ApplicationFiled: September 30, 2009Publication date: April 29, 2010Inventor: LETHA J. SOOTER
-
Publication number: 20100047924Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.Type: ApplicationFiled: August 13, 2009Publication date: February 25, 2010Applicants: NanoString Technologies, Inc.Inventors: Philippa J. WEBSTER, Tim DAHL, Craig E. Dahl
-
Patent number: 7662550Abstract: The invention provides assays that can detect multiple genetic variants of a gene (e.g., a mycobacterial gene) in a sample using a pool (e.g., 2, 3, 4, or more) of oligonucleotide hybridization probes.Type: GrantFiled: October 13, 2000Date of Patent: February 16, 2010Assignee: PHRI Properties, Inc.Inventors: Sanjay Tyagi, Fred R. Kramer, David Alland
-
Publication number: 20100029008Abstract: The present invention concerns methods of polymerase independent template directed elongation of polynucleotides, nucleotide building blocks used in these methods as well as the use of the methods and building blocks for the determination of nucleotide sequences, in particular for the determination of SNPs, base modifications, mutations, rearrangements and methylation patterns.Type: ApplicationFiled: December 12, 2005Publication date: February 4, 2010Applicant: FEBIT BIOTECH GMBHInventors: Jan André Rojas Stütz, Eric Kervio, Clemens Richert, Patrizia Hagenbuch, Annette Hochgesand, Niels Griesang, Stephanie Vogel, Ulrich Plutowski
-
Patent number: 7655401Abstract: In one aspect, the invention provides methods of identifying genetic mutations that are associated with ataxic neurological disease. The methods comprise identifying a difference between a nucleic acid sequence of a protein kinase C gamma gene from a mammalian subject exhibiting ataxia and a nucleic acid sequence of a protein kinase C gamma gene from a subject which is not exhibiting ataxia, wherein the difference is a genetic mutation associated with ataxic neurological disease. In another aspect, isolated nucleic acid molecules encoding protein kinase C gamma missense mutations are provided. In another aspect, a method of screening a subject to determine if the subject has a genetic predisposition to develop an ataxic neurological disease is provided. In another aspect, the invention provides kits for determining susceptibility or presence of ataxic neurological disease in a mammalian subject.Type: GrantFiled: September 25, 2003Date of Patent: February 2, 2010Assignee: University of WashingtonInventors: Wendy H. Raskind, Dong-Hui Chen, Thomas D. Bird, Zoran Brkanac
-
Patent number: 7601851Abstract: Dye reagents useful in labeling biological materials are provided along with methods for their use.Type: GrantFiled: May 10, 2005Date of Patent: October 13, 2009Assignee: Epoch Biosciences, Inc.Inventors: Eugeny A. Lukhtanov, Alexei V. Vorobiev, Michael W. Reed, Nicolaas M. J. Vermeulen
-
Publication number: 20090246762Abstract: Disclosed are methods and kits applicable to sequencing methods, such as Sanger dideoxy sequencing methods. The methods and kits disclosed utilize a cationically charged nucleic acid terminator in combination with a discriminatory polymerase.Type: ApplicationFiled: March 31, 2008Publication date: October 1, 2009Applicant: APPLERA CORPORATION, APPLIED BIOSYSTEMS GROUPInventors: Barnett B. Rosenblum, Steven M. Menchen
-
Publication number: 20090240030Abstract: This invention provides methods for covalently affixing a biomolecule to either a second molecule or a solid surface using 1,3-dipolar cycloaddition chemistry. This invention also provides related methods and compositions.Type: ApplicationFiled: December 19, 2008Publication date: September 24, 2009Inventors: Jingyue Ju, Tae Seok Seo
-
Patent number: 7585624Abstract: A cryogenic detector is used for detection in a biological assay.Type: GrantFiled: March 5, 2004Date of Patent: September 8, 2009Assignee: University of LeicesterInventors: George William Fraser, Andrew David Holland, Gertrude Maria Schwarzacher, John Seymour Heslop-Harrison
-
Patent number: 7585964Abstract: Probes and methods of using the probes to detect chromosomal rearrangements and/or deletions are provided. The methods utilize probes that are free of repeat sequences to provide greater selectivity and sensitivity; methods for producing such probes are also disclosed. The probe sets utilized in the detection methods are designed to hybridize to chromosomes at regions outside known breakpoints, instead of spanning the breakpoint as with conventional FISH methods, and, in some instances, are further designed to bind to regions located outside the genes involved in the rearrangement. Methods utilizing probe sets with two and four colors are also described, as are automated methods for analyzing rearrangements.Type: GrantFiled: May 14, 2002Date of Patent: September 8, 2009Assignee: Cancer Genetics, Inc.Inventors: Nallasivam Palanisamy, Raju S. Chaganti
-
Patent number: 7582260Abstract: The invention relates to compositions and methods useful in the labeling and identification of proteins. The invention provides for highly soluble zwitterionic dye molecules where the dyes and associated side groups are non-titratable and maintain their net zwitterionic character over a broad pH range, for example, between pH 3 and 12. These dye molecules find utility in a variety of applications, including use in the field of proteomics.Type: GrantFiled: January 20, 2004Date of Patent: September 1, 2009Assignee: Montana State UniversityInventors: Edward A. Dratz, Paul A. Grieco
-
Patent number: 7582421Abstract: This application includes methods for detecting single nucleotide polymorphisms (SNPs) in a sample using an electronically addressable microchip having a plurality of test sites. A sample nucleic acid is electronically biased, concentrated at, and immobilized to a test site on the microchip. A mixture comprising a first labeled probe and a second labeled probe is electronically hybridized to the sample nucleic acid to form first or second hybridized complexes. The first labeled probe is perfectly complementary to the first sample nucleic acid and the second labeled probe is complementary to the sample nucleic acid and contains a nucleotide that forms a mismatch with the nucleotide at the site of the polymorphism. The first or second hybridized complexes are detected by determining a signal intensity of the label of the first or second probe.Type: GrantFiled: September 16, 2002Date of Patent: September 1, 2009Assignee: Nanogen, Inc.Inventors: Ronald G. Sosnowski, Michael I. Nerenberg, David M. Canter, Ray R. Radtkey, Ling Wang, James P. O'Connell
-
Publication number: 20090215188Abstract: The present invention relates to a method for labeling biological molecules of interest contained in a biological sample, consisting in: a) providing a reaction vessel, b) immobilizing capture molecules, which are capable of binding a label of the biological molecules of interest, on a solid support of the vessel, c) introducing the biological sample but also at least one label of the biological molecules of interest into said vessel and optionally any ingredient required for labeling or prelabeling the molecules of interest, d) incubating the vessel content and immobilizing the label which is not reacted with the molecules of interest by binding to the capture molecules, and e) using the labeled molecules of interest for subsequent steps. A method for treating a biological sample is also disclosed. Said invention is preferably used in a manual or automated method for purifying nucleic acids.Type: ApplicationFiled: May 31, 2006Publication date: August 27, 2009Applicant: BIOMERIEUXInventors: Eloy Bernal-Mendez, Ali Laayoun, Lionel Menou